Subjects: FIBRINOLYTIC agents; BLOOD coagulation disorders; ANTICOAGULANTS
Record details
Subjects: HEMOPHILIA; BLOOD coagulation disordersUNITED StatesBAYER Biological Products (Company) ; BAYER HealthCare AG ; CENTERS for Disease Control & Prevention (U.S.)
Subjects: SWOT analysis; PROTEIN fractionation; BLOOD coagulation disordersOCTAPHARMA AG
Subjects: DRUG development; HYPOGLYCEMIC agents; TREATMENT of diabetesNOVO Nordisk A/S
Subjects: BUSINESS finance; BUSINESS cycles; INDUSTRIAL locationNOVO Nordisk A/S
Subjects: BUSINESS finance; BUSINESS cycles; INDUSTRIAL locationGTC Biotherapeutics Inc.
Subjects: *MARKET potential; TRANSLUMINAL angioplasty; MYOCARDIAL infarction treatment